Pharmacology of new antimalarial drugs: RC 12, sodium antimony salt of astiban and kethoxal-bis-thiosemicarbazone.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D000965:Antimony / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects*; D002415:Cats; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D008288:Malaria / Q000188:drug therapy; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D009541:Nictitating Membrane / Q000187:drug effects; D051381:Rats; D012119:Respiration / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology; D013386:Succinates / Q000494:pharmacology*; D013882:Thiosemicarbazones / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D000962:Antimalarials; D013386:Succinates; D013882:Thiosemicarbazones; D012701:Serotonin; D006632:Histamine; D000965:Antimony; D000109:Acetylcholine; D004837:Epinephrine